KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,930,000 | -54.1% | 274,900 | -39.1% | 0.01% | -58.6% |
| Q4 2014 | $6,390,000 | +123.7% | 451,565 | +117.3% | 0.03% | +107.1% |
| Q3 2014 | $2,857,000 | -14.8% | 207,800 | -4.7% | 0.01% | -12.5% |
| Q2 2014 | $3,353,000 | +6.4% | 218,000 | +17.9% | 0.02% | 0.0% |
| Q1 2014 | $3,151,000 | +75.6% | 184,900 | +33.5% | 0.02% | +77.8% |
| Q4 2013 | $1,794,000 | – | 138,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |